Investors
Andera Partners
https://anderapartners.comAndera Partners, based in Paris, manages $3.6 billion across multiple funds, focusing on early and late-stage venture investments. Their main areas of interest are tech, health, and energy sectors. Notable investments include Tubulis, HR Path, ReViral, Nouscom, and FIRE1. They participate in different funding rounds, including Series A through D, with varied check sizes.
Recent Investments
- NouscomSeries C(
48 ) - Grey Wolf TherapeuticsSeries B( 44 )
- TubulisSeries B( 56 )
- SciRhomSeries A( 53 )
- ENYO PharmaSeries C( 52 )
- DualyxSeries A( 41 )
- Ariceum TherapeuticsSeries A( 52 )
- Mylight150Series D( 48 )
- TubulisUnknown( 56 )
- TargED BiopharmaceuticalsSeries A( 34 )
- ImCheck TherapeuticsUnknown( 48 )
- SirsaUnknown( 25 )
- ExcivaSeries A( 28 )
- LhyfeUnknown( 40 )
- ReViralSeries C( 52 )
- MedlumicsUnknown( 40 )
- HR PathUnknown( 60 )
- FIRE1Series C( 52 )
- mmiSeries A( 40 )
- ENYO PharmaSeries B( 52 )
- Grey Wolf TherapeuticsSeries A( 44 )
- MedlumicsSeries B( 40 )